HiSiaddi is an innovative foreign trade service provider driven by dual pillars of technology commercialization and export services. We have established a "1+2+3+4=1" service system and can supply rhodium(II) octanoate sourced from multiple well-known original manufacturers.
As a research-driven foreign trade enterprise, HiSiaddi has conducted multiple rounds of factory inspections for rhodium(II) octanoate manufacturers and developed objective, in-depth insights into various brands. We regularly analyze different rhodium(II) octanoate manufacturers for clients to help select matching products. Below is a brand recommendation case.
Contact HiSiaddi customer service for more brand and model comparison analysis.
BioSynth GmbH of Hamburg, Germany, is a mid-to-high-end custom API CDMO in Europe specializing in industrial production of carbapenem antibiotics and cyclopropane targeted intermediates. The enterprise previously purchased Johnson Matthey pharmaceutical-grade rhodium(II) octanoate from the UK annually with a volume of 55 kg. Faced with surging European rhodium raw material prices and extended manufacturer lead times of up to 90 days, the client planned to switch to localized Chinese sourcing.
Client Pain Points: Unfamiliarity with domestic rhodium(II) octanoate brand tiers and model application scenarios. The client separately contacted five source manufacturers (Guiyan, Xi’an Kaili, Hangzhou Kaida, Shanghai Aladdin, Hubei Jusheng) for quotations and sample deliveries. Each manufacturer only promoted its own products without maliciously disparaging competitors but avoided objective comparisons of rival strengths and weaknesses. The client received five samples with vastly different parameters and quotations, unable to screen matching models based on its own production process. High trial costs stalled model selection, prompting the client to entrust HiSiaddi with full neutral evaluation of all brands and targeted recommendations.
Aligned with the client’s rigid operating standards for pharmaceutical API mass production, USP pharmacopoeia compliance, D50 particle size 18–23 μm, free octanoic acid ≤150 ppm, and rhodium content 26.5%±0.05%, HiSiaddi conducted on-site factory verification of quality control, production lines, and testing capabilities for all five brands, objectively breaking down each brand’s strengths, weaknesses, and core product models:
· Core Models: GY-YX Pharmacopoeia Grade, GY-GX Fine Custom Grade
· Strengths: Participated in drafting national rhodium(II) octanoate standards; self-smelted traceable rhodium raw materials; stable heavy metal impurities <7 ppm; full closed-loop production line suitable for long-term large-scale pharmaceutical mass production.
· Weaknesses: Long delivery cycles for small customized batches (<5 kg per order); standard mass-produced grades feature wide particle size distribution (D50 10–35 μm).
· Applicable Scenarios: Medium-to-large scale continuous pharmaceutical mass production.
· Core Models: KL-Y Pharmaceutical Refined Grade, KL-S Laboratory High-Purity Reagent Grade
· Strengths: Mature directional crystal growth technology enabling precise particle size control; excellent free organic acid residue control; flexible small-batch customization with fast scheduling for 1–5kg orders.
· Weaknesses: Limited mass production capacity for large orders; unit price slightly higher than leading state-owned manufacturers.
· Applicable Scenarios: New drug R&D medium-scale trials, small-batch refined synthesis.
· Core Models: KD-P Industrial Pharmacopoeia Grade, KD-C Modified Antioxidant Special Grade
· Strengths: Industry-university-research cooperation with Zhejiang University; modified formulations with inert antioxidant additives for strong long-term storage stability; compatible with automated closed feeding production lines.
· Weaknesses: General industrial grades feature loose impurity control; high-purity customized grades carry high minimum order quantities.
· Applicable Scenarios: Automated continuous pharmaceutical production lines.
· Core Model: AL-R High-Purity Laboratory Reagent Grade
· Strengths: Complete small-weight packaging (200mg–5g in stock); full supporting test reports ideal for laboratory small trials.
· Weaknesses: High unit price for kilogram-level industrial orders; no dedicated mass-production large-batch customization capacity, incompatible with the client’s 55kg annual mass production demand.
· Applicable Scenarios: Laboratory research and development – excluded from the client’s mass production candidate list.
· Core Model: JS-T General Industrial Grade
· Strengths: Sufficient off-the-shelf inventory at low prices; stable supply of 25kg bulk packaging for mass production.
· Weaknesses: Free octanoic acid residues generally exceed 300 ppm; rhodium content fluctuates ±0.3%, failing to meet European USP pharmaceutical access standards.
· Applicable Scenarios: General fine chemical production – excluded from the client’s high-end pharmaceutical procurement candidate list.
Eliminating Aladdin and Jusheng due to poor compatibility, three models from the two qualified mid-to-high-end brands (Guiyan and Xi’an Kaili) were finalized to satisfy both mass production and small-scale R&D demands:
1. Guiyan GY-YX Pharmacopoeia Grade (Primary Mass Production Model): For the client’s annual 55kg regular bulk stock, delivering precise rhodium content of 26.48%–26.52% and heavy metals <6 ppm, compatible with the client’s core antibiotic production line, cutting costs by 33% versus imported alternatives.
2. Xi’an Kaili KL-Y Pharmaceutical Refined Grade: For small-batch new drug medium-scale trial procurement, delivering stable D50 particle size around 20 μm with no agglomeration during pre-dissolution, ideal for new formulation R&D feeding.
3. Xi’an Kaili KL-S High-Purity Custom Grade: Spare standby model for cutting-edge new drug projects requiring ultra-strict impurity control.
HiSiaddi compiled a bilingual Chinese-English Horizontal Comparison Whitepaper of Five Major Brands, labeling COA indicators, storage stability, feeding compatibility, and unit price ranges for all models, and submitted the document to the client’s German technical department for review.
1. Three Rounds of Sample Testing HiSiaddi coordinated free sample delivery of the three preferred models from both manufacturers. Three consecutive batches of small-scale trials conducted in the client’s German laboratory yielded a cyclization catalytic yield of 95.1% for Guiyan GY-YX mass production grade, matching original Johnson Matthey imported catalysts. The two Kaili medium-trial grades reduced reaction by-product impurities by 12%, fully complying with the client’s drug regulatory registered production process.
2. Order Sign-Off First shipment: 30 kg total (22 kg Guiyan GY-YX + 8 kg Kaili KL-Y). The remaining 25 kg is delivered in quarterly batches under a signed annual framework procurement agreement.
3. Supporting Services HiSiaddi centrally coordinated export SDS, REACH documents, batch traceability reports, and customized 1kg argon vacuum aluminum foil packaging, enabling smooth customs clearance at the Port of Hamburg.
1. The client formally terminated long-term procurement from Johnson Matthey and fully shifted annual rhodium(II) octanoate sourcing to domestic Chinese suppliers. Comprehensive procurement costs decreased by 32.8%, and lead times were shortened from 90 days to 22–28 days.
2. The client added catalyst procurement demand for two new pipeline drugs the following year, continuing to rely on HiSiaddi for brand selection and sourcing.
3. The client referred two other high-end European CDMO pharmaceutical enterprises from the Netherlands and Austria to HiSiaddi for domestic precious metal catalyst brand evaluation and sourcing.
It is standard industry practice for domestic manufacturers to only promote their own products and avoid objective disclosure of competitor strengths, driven by sales objectives. Mid-to-high-end overseas pharmaceutical enterprises operate with extremely low tolerance for selection errors due to pharmacopoeia and mass production process constraints. Leveraging professional expertise in precious metals, HiSiaddi conducted neutral cross-brand evaluations independent of single-manufacturer sales bias, accurately matching products to client process requirements. Long-term cooperative relationships with high-end clients were secured through specialized brand selection expertise.
Contact HiSiaddi customer service for more brand and model comparison analysis.
+86-13120989737 
info@hisiaddi.com 
English
